Pharmaceuticals - Community Register


List of nationally authorised medicinal products for human use


Product name: Xalatan
Also marketed in the EU under the name(s): Latanoprost Pharmacia & Upjohn
Active substance: latanoprost
Indication: Reduction of elevated intraocular pressure in adult patients with open angle glaucoma and ocular hypertension.
Marketing Authorisation Holder: Pfizer Limited

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
18/10/2010 Referral EMEA/H/A-29/PAD/1270 (2010)7267 of 15/10/2010